Search Results - "Mahant, Aakash Mahant"
-
1
Failure of Herpes Simplex Virus Glycoprotein D Antibodies to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines
Published in The Journal of infectious diseases (01-11-2022)“…The glycoprotein D (gD)/AS04 vaccine failed to prevent herpes simplex virus (HSV) 2 in clinical trials. Failure was recapitulated in mice, in which the vaccine…”
Get full text
Journal Article -
2
Prolonged Preterm Rupture of Membranes Associated with Neonatal Disseminated Herpes Simplex Virus Type 1 at Birth: Is There a Role for Preemptive Test and Treat Strategies in High-Risk Populations?
Published in Journal of the Pediatric Infectious Diseases Society (28-04-2023)Get full text
Journal Article -
3
90 Placental transfer of SARS-CoV-2 specific antibodies from mothers to newborns
Published in American journal of obstetrics and gynecology (01-02-2021)Get full text
Journal Article -
4
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
Published in The Journal of clinical investigation (01-02-2023)“…There is an unmet need for monoclonal antibodies (mAbs) for prevention or as adjunctive treatment of herpes simplex virus (HSV) disease. Most vaccine and mAb…”
Get full text
Journal Article -
5
Novel Mouse Model of Recurrent Sublethal Herpes Simplex Virus Infection Recapitulates Human Antibody Responses to Primary and Chronic Infection
Published in Vaccines (Basel) (01-10-2024)“…Herpes simplex virus (HSV) vaccine development has been impeded by the absence of predictive preclinical models and defined correlates of immune protection…”
Get full text
Journal Article -
6
Antibodies Elicited in Response to a Single Cycle Glycoprotein D Deletion Viral Vaccine Candidate Bind C1q and Activate Complement Mediated Neutralization and Cytolysis
Published in Viruses (30-06-2021)“…Herpes simplex virus (HSV) prevention is a global health priority but, despite decades of research, there is no effective vaccine. Prior efforts focused on…”
Get full text
Journal Article -
7
Humoral Immune Responses to HSV Infections and Placental Transfer of Protective Antibodies; Implications for HSV Vaccine and Monoclonal Antibody Development
Published 01-01-2023“…Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2, respectively) are two of the most prevalent human viruses worldwide. They cause significant global…”
Get full text
Dissertation -
8
2125. Determinants of Placental Transfer of HSV-specific Antibodies and the Impact of SARS-CoV-2 Coinfection
Published in Open forum infectious diseases (15-12-2022)Get full text
Journal Article -
9
Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle ΔgD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine
Published in Vaccines (Basel) (14-08-2023)“…Herpes simplex viruses (HSV) cause chronic infections with significant morbidity. Prior vaccines, designed to generate neutralizing antibodies (nAbs) targeting…”
Get full text
Journal Article -
10
Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
Published in Human vaccines & immunotherapeutics (03-08-2017)“…One of the critical issues that should be addressed in the development of a BCG-based HIV vaccine is genetic plasmid stability. Therefore, to address this…”
Get full text
Journal Article -
11
1192: Placental transfer of HSV-specific antibodies from mothers to newborns
Published in American journal of obstetrics and gynecology (01-01-2020)Get full text
Journal Article -
12
Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2
Published in The Journal of infectious diseases (18-02-2020)“…Abstract Background Neonatal herpes simplex virus (HSV) disease results in unacceptable morbidity and mortality. The primary humoral immune response to natural…”
Get full text
Journal Article -
13
Preclinical development of BCG.HIVA 2auxo.int , harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
Published in Human vaccines & immunotherapeutics (03-08-2017)“…One of the critical issues that should be addressed in the development of a BCG-based HIV vaccine is genetic plasmid stability. Therefore, to address this…”
Get full text
Journal Article